http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2191777-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3e9d77ff72f5282325b4e142dfa5b4c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 1995-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22a41871e18d6f3fc8e748817c0ec65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63a6117a5ff206cf2a1714b456f47e9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7484dd692565488e75693b581917041b |
| publicationDate | 1995-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2191777-A1 |
| titleOfInvention | Cyclodextrin cellular delivery system for oligonucleotides |
| abstract | Disclosed is a composition including an oligonucleotide complexed with a cyclode xtrin. The oligonucleotide may be noncovalently associated with the cyclodextrin. Alternatively, the oligonucleotide may be cova lently complexed with adamantane which is noncovalently associated with the cyclodextrin. Also disclosed are methods of enhancing the ce llular uptake and intracellular concentration of oligonucleotides, methods of increasing the solubility of an oligonucleotide in a cell, and methods of treating a cell for viral infection or to prevent viral infection. |
| priorityDate | 1994-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.